Neonatal thrombo-embolism: Risk factors, clinical features and outcome

Annals of Tropical Paediatrics

Volumn 29, Issue 4, 2009, Pages 271-279

  Demirel, N ^a   Aydin, M ^a   Zenciroglu, A ^a   Bas, A Y ^a   Yarali, N ^b   Okumus, N ^a   Cinar, G ^b   Ipek, M S ^a  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b Dr Sami Ulus Maternity and Children's Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE;

ANGIOGRAPHY; ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL FEATURE; CONGENITAL HEART DISEASE; DEHYDRATION; EXCHANGE BLOOD TRANSFUSION; FEMALE; FEMORAL ARTERY; FIBRINOLYTIC THERAPY; GENE MUTATION; HUMAN; ILIAC ARTERY; KIDNEY VEIN THROMBOSIS; MALE; MATERNAL DIABETES MELLITUS; MECONIUM ASPIRATION; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; OUTCOMES RESEARCH; PERINATAL ASPHYXIA; PNEUMONIA; POLYCYTHEMIA; PORTAL VEIN THROMBOSIS; PREMATURITY; RENAL ARTERY THROMBOSIS; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEPTICEMIA; THROMBOEMBOLISM; TREATMENT RESPONSE; UMBILICAL VEIN; VENOUS THROMBOEMBOLISM;

CATHETERIZATION, CENTRAL VENOUS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 70849097752     PISSN: 02724936     EISSN: 14653281     Source Type: Journal    
DOI: 10.1179/027249309X12547917868961     Document Type: Article

References (35)

1. Beardsley DS. Venous thromboembolism in the neonatal period. Semin Perinatol 2007; 31:250-253
2. Chalmers EA. Epidemiology of venous thromboembolism in neonates and children. Thromb Res 2006; 118:3-12.
3. Greenway A, Massicotte MP, Monagle P. Neonatal thrombosis and its treatment. Blood Rev 2004; 18:75-84.
4. Malowany JI, Monagle P, Knoppert DC, et al. Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates. Thromb Res 2008; 122:826-830
5. Morag I, Epelman M, Daneman A, et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr 2006; 148:735-739
6. Aslam M, Guglietti D, Hansen AR. Neonatal arterial thrombosis at birth: case report and literature review. Am J Perinatol 2008; 25:347-352
7. Nowak-Gö ttl U, Duering C, Kempf-Bielack B, Sträter R. Thromboembolic diseases in neonates and children. Pathophysiol Haemost Thromb 2003/ 2004; 33:269-274
8. Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pedriatr Hematol Oncol 1990; 12:95-104.
9. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995; 74:415-425
10. Debus O, Koch HG, Kurlemann G, et al. Factor V Leiden and genetic defects of thrombophilia in childhood porencephaly. Arch Dis Child Fetal Neonatal Ed 1998; 78:121-124
11. Gü nther G, Junker R, Sträter R, et al. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombotic risk factors. Stroke 2000; 31:2437-2441
12. Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998; 133:777-781
13. Heller C, Schobess R, Kurnik K, et al. Abdominal venous thrombosis in neonates and infants: Role of prothrombotic risk factors - a multicentre casecontrol study. For the Childhood Thrombophilia Study Group. Br J Haematol 2000; 111:534-539
14. Sträter R, Vielhaber H, Kassenböhmer R, Von Kries R, Göbel U, Nowak-Gö ttl U. Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999; 158:S122-5.
15. Nowak-Gö ttl U, von Kries R, Göbel U. Neonatal symptomatic thromboembolism in Germany: two year survey. Arch Dis Child Fetal Neonatal Ed 1997; 76:163-167
16. Bökenkamp A, Von Kries R, Nowak-Gö ttl U, Göbel U, Hoyer PF. Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome. Eur J Pediatr 2000; 159:44-48
17. Alvarez F, Bernard O, Brunelle F, Hadchouel P, Odievre M, Alagille D. Portal obstruction in children, I: clinical investigation and hemorrhage risk. J Pediatr 1983; 103:696-702.
18. Kim JH, Lee YS, Kim SH, Lee SK, Lim MK, Kim HS. Does umbilical vein catheterisation lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001; 219:645-650
19. Revel-Vilk S, Chan A, Bauman M, Massicotte P. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost 2003; 1:915-921
20. Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96:939-943
21. Nowak-Gottl U, Kosch A, Schlegel N. Neonatal thromboembolism. Semin Thromb Haemost 2003; 29:229-234
22. Seligsohn U, Zivelin A. Thrombophilia as a multigenic disorder. Thromb Haemost 1997; 78:297-301.
23. Lane A, Grant PJ. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95:1517-1526
24. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344:1222-1231
25. Koeleman BP, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84:1031-1035
26. Zö ller B, Berntsdotter A, García De Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85:3518-3523
27. Young G, Albisetti M, Bonduel M, et al. Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies. Circulation 2008; 118:1373-1382
28. Kyrle PA, Minar E, Hirschl M, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343:457-462
29. Goldenberg NA, Knapp-Clevenger R, Manco- Johnson MJ. Elevated plasma factor VIII and Ddimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 2004; 351:1081-1088
30. Manco-Johnson MJ, Nuss R, Key N, et al. Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis. J Pediatr 1996; 128:319-323
31. Male C, Mitchell L, Julian J, et al. Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in paediatric patients with systemic lupus erythematosus. Blood 2001; 97:844-9.
32. Deveber G, Monagle P, Chan A, et al. Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998; 55:1539-1543
33. Turebylu R, Salis R, Erbe R, Martin D, Lakshminrusimha S, Ryan RM. Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis. J Perinatol 2007; 27:490-495
34. Michaels LA, Gurian M, Hegyi T, Drachtman RA. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics 2004; 114:703-707
35. Andrew M, Brooker L, Leaker M, Paes B, Weitz J. Fibrin clot lysis by thromboembolic agents is impaired in newborns due to a low plasminogen concentration. Thromb Haemost 1992; 68:325-330